Search

everythinglearnresearchcommunity

for

Search:↓

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride reduces hair growth and is safe for women with excessive hair.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Oral pigmentation can be a sign of Addison's disease.

Some skin diseases and their treatments can negatively affect male fertility.

New treatments for PCOS focus on managing symptoms and improving fertility.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Certain gene variations might be linked to severe acne in women but not in men.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.